KEGG   DRUG: Glycopyrronium bromide and indacaterol maleateHelp
Entry
D10505            Mixture   Drug                                   

Name
Glycopyrronium bromide and indacaterol maleate;
Ultibro (TN)
Product
Component
Glycopyrronium bromide [DR:D00540], Indacaterol maleate [DR:D09319]
Remark
Therapeutic category: 2259
ATC code: R03AL04
Product: D10505<JP/US>
Efficacy
Bronchodilator
  Disease
Chronic obstructive pulmonary disease [DS:H01714]
Comment
Indacaterol is metabolized by CYP3A4 and P-gp.
Metabolism
Enzyme: CYP3A4 [HSA:1576]
Transporter: ABCB1 [HSA:5243]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
   R03A ADRENERGICS, INHALANTS
    R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
     R03AL04 Indacaterol and glycopyrronium bromide
      D10505  Glycopyrronium bromide and indacaterol maleate <JP/US>
USP drug classification [BR:br08302]
 Respiratory Tract/Pulmonary Agents
  Bronchodilators, Other
   Indacaterol/ Glycopyrrolate
    D10505  Glycopyrronium bromide and indacaterol maleate
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  22  Respiratory organ agents
   225  Bronchodilators
    2259  Others
     D10505  Glycopyrronium bromide and indacaterol maleate
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10505
BRITE hierarchy
Other DBs
PubChem: 172232598
ChEBI: 90962
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system